Loading clinical trials...
Loading clinical trials...
First Stage 3D-ultrasound During Prolonged Labour.
This observational study is designed to correlate findings on ultrasound with manual palpation, and to consider if delivery outcome can be predicted with help of ultrasound. Specifically, the study will evaluate the significance of fetal head level (descent) in the pelvis, measured with ultrasound.
AIM: To correlate findings on ultrasound with manual palpation, and to consider if delivery outcome can be predicted with help of ultrasound. Specifically evaluate the significance of fetal head level (descent) in the pelvis, measured with ultrasound. Objective: Labours have traditionally been evaluated by manuals methods of the "delivery helper" - midwives or doctor. There are many factors that will prolong labour such as malcontractions, disproportion of the birth canal and malpresentation/position. In about 20% of primigravidae, the first stage will last longer than 10 hours. In this study we want to evaluate different ultrasounds measurements to see if ultrasound can be used to predict the outcome of labour. Methods: A descriptive observational study, with one ultrasound examination. The labour will be handled according to definitions by Woman's department, Stavanger University Hospital, and WHO. The use of stimulating agents, as Oxytocin, will be evaluated after manual examinations, specific definitions and criteria. The results of the ultrasound examinations will be evaluated after the delivery, since the results are not to be used clinically during the delivery. Inclusion criteria will be primigravidae, with one fetus, after the 37th week. Feta head presentation. Ruptured membranes, at least one hour before inclusion. Prolonged first stage according to WHO definitions. The target is to include 100 subjects. Inter- and intraobserver variation will be evaluated with intraclass coefficients. We will analyze operative delivery with normal vaginal delivery. Also, two groups divided by the stage 0 will be evaluated with statistics analyzes. Time to delivery will be evaluated with Kaplan Meier and Cox regression analyzes.
Age
All ages
Sex
FEMALE
Healthy Volunteers
No
Stavanger University Hospital
Stavanger, Norway
Start Date
November 1, 2008
Primary Completion Date
August 1, 2010
Completion Date
August 1, 2010
Last Updated
April 26, 2016
110
ACTUAL participants
Ultrasound examination
OTHER
Lead Sponsor
Helse Stavanger HF
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions